Cipla To Buy Foreign Partners To Become Local Company In Key Markets
This article was originally published in PharmAsia News
Cipla plans to turn more of its foreign partnerships into acquisitions, particularly in emerging markets, as it follows a new strategy for becoming even more of a global player in the drug industry.
You may also be interested in...
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.
Pharma pays $50m up front to tap insitro’s in vitro modeling technology, partners with Sensyne Health in blood disorders. Lilly’s COVID-19 partner AbCellera teams with Kodiak in ophthalmology R&D.